PRS9 - SWITCHING FROM SUBCUTANEOUS TREPROSTINIL TO INHALED TREPROSTINIL IN PULMONARY ARTERIAL HYPERTENSION TREATMENT AND ECONOMIC IMPACT EVALUATION
Abstract
Authors
I. Moya-Carmona M. Pedrosa Ruiz C. Estaun-Martinez J. Ortiz M.R. Mora-Santiago